MedPath

Will Erectile Dysfunction Increase the Risk of Prostate Cancer

Completed
Conditions
Erectile Dysfunction
Interventions
Other: Erectile dysfunction
Registration Number
NCT03009123
Lead Sponsor
Kuang Tien General Hospital
Brief Summary

The rationale for investigating the hypothesis that there is an association between erectile dysfunction (ED) and the subsequent development of prostate cancer is based on three assumptions: 1) baseline ED is common in most if not all of the cross-sectional studies in men with prostate cancer; 2) the development of ED and prostate cancer may have certain shared common risk factors; and 3) the use of testosterone for the treatment of ED has been suspected to be associated with prostate cancer development. Controversy exists over whether men with ED have an increased risk of subsequent prostate cancer. Few studies have evaluated the risk of developing prostate cancer for men with ED. The investigators, therefore, conducted a population-based longitudinal study with eight years' follow-up to examine this association and to evaluate the magnitude of the risk.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
21558
Inclusion Criteria
  • men 50 years and older with no pre-existing prostate cancer
Exclusion Criteria
  • less than 50 years old
  • pre-existing prostate cancer

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Erectile dysfunction groupErectile dysfunctionGroup contains men with physician-diagnosed erectile dysfunction
Primary Outcome Measures
NameTimeMethod
Incident prostate cancerthrough study completion, up to 7 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Kuang Tien General Hospital

🇨🇳

Taichung, Taiwan

© Copyright 2025. All Rights Reserved by MedPath